<div class="tables rowsep-0 colsep-0 frame-topbot" id="tbl0001">
<div class="captions"><span id="cap0002"><p id="spara0008"><span class="label">Table 1</span>. Patient demographics and baseline characteristics (mean values [SD] unless otherwise indicated).</p></span></div>
<div class="groups"><table>
<thead>
<tr>
<th scope="col" class="align-left valign-top" id="en0001"></th>
<th scope="col" class="align-left valign-top" id="en0002"></th>
<th scope="col" class="align-center valign-top rowsep-1" id="en0003" colspan="3">Baseline CRP</th>
<th scope="col" class="align-left valign-top" id="en0004"></th>
</tr>
<tr class="rowsep-1">
<th scope="col" class="align-left valign-top" id="en0001a">Characteristic</th>
<th scope="col" class="align-left valign-top" id="en0002a">Category</th>
<th scope="col" class="align-left valign-top" id="en0007">Normal (≤ ULN) <em>n</em> = 371</th>
<th scope="col" class="align-left valign-top" id="en0008">High (&gt; ULN and ≤ 3xULN) (<em>n</em> = 299)</th>
<th scope="col" class="align-left valign-top" id="en0009">Very high (&gt; 3xULN) <em>n</em> = 197</th>
<th scope="col" class="align-left valign-top" id="en0004a">Total <em>n</em> = 867</th>
</tr>
</thead>
<tbody>
<tr>
<td class="align-left valign-top" id="en0011">Men, <em>n</em> (%)<a name="btb1fn1" href="#tb1fn1" class="workspace-trigger">*</a>
</td>
<td class="align-left valign-top" id="en0012"></td>
<td class="align-left valign-top" id="en0013">247 (66.6)</td>
<td class="align-left valign-top" id="en0014">231 (77.3)</td>
<td class="align-left valign-top" id="en0015">164 (83.3)</td>
<td class="align-left valign-top" id="en0016">642 (74.1)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0017">Age at disease onset, years<a name="btb1fn1" href="#tb1fn1" class="workspace-trigger">*</a>
</td>
<td class="align-left valign-top" id="en0018"></td>
<td class="align-left valign-top" id="en0019">34.7 (11.4)</td>
<td class="align-left valign-top" id="en0020">31.0 (10.2)</td>
<td class="align-left valign-top" id="en0021">29.5 (9.9)</td>
<td class="align-left valign-top" id="en0022">32.3 (10.9)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0023" rowspan="2">Age at disease onset, <em>n</em> (%)<a name="btb1fn1" href="#tb1fn1" class="workspace-trigger">*</a>
</td>
<td class="align-left valign-top" id="en0024">≤40 years</td>
<td class="align-left valign-top" id="en0025">259 (69.8)</td>
<td class="align-left valign-top" id="en0026">243 (81.3)</td>
<td class="align-left valign-top" id="en0027">169 (85.8)</td>
<td class="align-left valign-top" id="en0028">671 (77.4)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0030">&gt;40 years</td>
<td class="align-left valign-top" id="en0031">112 (30.2)</td>
<td class="align-left valign-top" id="en0032">55 (18.4)</td>
<td class="align-left valign-top" id="en0033">28 (14.2)</td>
<td class="align-left valign-top" id="en0034">195 (22.5)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0035">Duration of AS, years</td>
<td class="align-left valign-top" id="en0036"></td>
<td class="align-left valign-top" id="en0037">8.6 (8.8)</td>
<td class="align-left valign-top" id="en0038">9.2 (9.0)</td>
<td class="align-left valign-top" id="en0039">8.9 (8.6)</td>
<td class="align-left valign-top" id="en0040">8.9 (8.8)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0041" rowspan="2">Duration of AS, <em>n</em> (%)</td>
<td class="align-left valign-top" id="en0042">≤5 years</td>
<td class="align-left valign-top" id="en0043">175 (47.2)</td>
<td class="align-left valign-top" id="en0044">129 (43.1)</td>
<td class="align-left valign-top" id="en0045">86 (43.7)</td>
<td class="align-left valign-top" id="en0046">390 (45.0)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0048">&gt;5 years</td>
<td class="align-left valign-top" id="en0049">196 (52.8)</td>
<td class="align-left valign-top" id="en0050">169 (56.5)</td>
<td class="align-left valign-top" id="en0051">111 (56.4)</td>
<td class="align-left valign-top" id="en0052">476 (54.9)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0053" rowspan="2">Prior NSAID, <em>n</em> (%)<a name="btb1fn4" href="#tb1fn4" class="workspace-trigger"><sup>a</sup></a>
</td>
<td class="align-left valign-top" id="en0054">No</td>
<td class="align-left valign-top" id="en0055">52 (14.0)</td>
<td class="align-left valign-top" id="en0056">33 (11.0)</td>
<td class="align-left valign-top" id="en0057">18 (9.1)</td>
<td class="align-left valign-top" id="en0058">103 (11.9)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0060">Yes</td>
<td class="align-left valign-top" id="en0061">319 (86.0)</td>
<td class="align-left valign-top" id="en0062">266 (89.0)</td>
<td class="align-left valign-top" id="en0063">179 (90.9)</td>
<td class="align-left valign-top" id="en0064">764 (88.1)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0065">CRP, mg/L<a name="btb1fn1" href="#tb1fn1" class="workspace-trigger">*</a>
</td>
<td class="align-left valign-top" id="en0066"></td>
<td class="align-left valign-top" id="en0067">4.8 (1.9)</td>
<td class="align-left valign-top" id="en0068">16.4 (5.3)</td>
<td class="align-left valign-top" id="en0069">49.5 (23.9)</td>
<td class="align-left valign-top" id="en0070">19.0 (21.0)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0071" rowspan="2">HLA-B27, <em>n</em> (%)<a name="btb1fn2" href="#tb1fn2" class="workspace-trigger"><sup>⁎⁎</sup></a>
</td>
<td class="align-left valign-top" id="en0072">Negative</td>
<td class="align-left valign-top" id="en0073">78 (21.0)</td>
<td class="align-left valign-top" id="en0074">43 (14.4)</td>
<td class="align-left valign-top" id="en0075">21 (10.7)</td>
<td class="align-left valign-top" id="en0076">142 (16.4)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0078">Positive</td>
<td class="align-left valign-top" id="en0079">284 (76.6)</td>
<td class="align-left valign-top" id="en0080">251 (84.0)</td>
<td class="align-left valign-top" id="en0081">171 (86.8)</td>
<td class="align-left valign-top" id="en0082">706 (81.4)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0083">PtGA<a name="btb1fn3" href="#tb1fn3" class="workspace-trigger"><sup>⁎⁎⁎</sup></a>
</td>
<td class="align-left valign-top" id="en0084"></td>
<td class="align-left valign-top" id="en0085">62.3 (20.7)</td>
<td class="align-left valign-top" id="en0086">62.6 (20.8)</td>
<td class="align-left valign-top" id="en0087">67.4 (20.3)</td>
<td class="align-left valign-top" id="en0088">63.6 (20.7)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0089">ASDAS-CRP<a name="btb1fn1" href="#tb1fn1" class="workspace-trigger">*</a>
</td>
<td class="align-left valign-top" id="en0090"></td>
<td class="align-left valign-top" id="en0091">3.2 (0.7)</td>
<td class="align-left valign-top" id="en0092">3.8 (0.6)</td>
<td class="align-left valign-top" id="en0093">4.6 (0.7)</td>
<td class="align-left valign-top" id="en0094">3.7 (0.9)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0095">BASDAI<a name="btb1fn2" href="#tb1fn2" class="workspace-trigger"><sup>⁎⁎</sup></a>
</td>
<td class="align-left valign-top" id="en0096"></td>
<td class="align-left valign-top" id="en0097">58.9 (16.5)</td>
<td class="align-left valign-top" id="en0098">58.5 (16.7)</td>
<td class="align-left valign-top" id="en0099">63.1 (17.0)</td>
<td class="align-left valign-top" id="en0100">59.7 (16.8)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0101">BASFI<a name="btb1fn1" href="#tb1fn1" class="workspace-trigger">*</a>
</td>
<td class="align-left valign-top" id="en0102"></td>
<td class="align-left valign-top" id="en0103">52.6 (20.5)</td>
<td class="align-left valign-top" id="en0104">56.8 (20.3)</td>
<td class="align-left valign-top" id="en0105">62.2 (19.5)</td>
<td class="align-left valign-top" id="en0106">56.2 (20.5)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0107">NBP</td>
<td class="align-left valign-top" id="en0108"></td>
<td class="align-left valign-top" id="en0109">61.5 (21.5)</td>
<td class="align-left valign-top" id="en0110">62.1 (22.6)</td>
<td class="align-left valign-top" id="en0111">65.9 (22.1)</td>
<td class="align-left valign-top" id="en0112">62.7 (22.1)</td>
</tr>
<tr>
<td class="align-left valign-top" id="en0113">TBP</td>
<td class="align-left valign-top" id="en0114"></td>
<td class="align-left valign-top" id="en0115">62.5 (20.2)</td>
<td class="align-left valign-top" id="en0116">62.0 (19.9)</td>
<td class="align-left valign-top" id="en0117">65.3 (21.1)</td>
<td class="align-left valign-top" id="en0118">62.9 (20.3)</td>
</tr>
</tbody>
</table></div>
<p class="legend"></p>
<p id="spara0009"><span><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/analysis-of-variance" title="Learn more about Analysis of Variance from ScienceDirect's AI-generated Topic Pages">One-way analysis of variance</a> with category as a factor was used to test for significance between continuous variables. </span><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/mantel-haenszel-test" title="Learn more about Mantel Haenszel Test from ScienceDirect's AI-generated Topic Pages">Cochran-Mantel-Haenszel test</a> of general association was used to test for significance between categorical parameters.</p>
<p id="spara0010"><span>AS, <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/ankylosing-spondylitis" title="Learn more about Ankylosing Spondylitis from ScienceDirect's AI-generated Topic Pages">ankylosing spondylitis</a><span>; ASDAS-CRP, Ankylosing Spondylitis Disease Activity Score–C-reactive protein; <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/basdai" title="Learn more about BASDAI from ScienceDirect's AI-generated Topic Pages">BASDAI</a><span>, <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/basdai" title="Learn more about BASDAI from ScienceDirect's AI-generated Topic Pages">Bath Ankylosing Spondylitis Disease Activity Index</a>; </span></span></span><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/bath-ankylosing-spondylitis-functional-index" title="Learn more about Bath Ankylosing Spondylitis Functional Index from ScienceDirect's AI-generated Topic Pages">BASFI</a><span>, <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/bath-ankylosing-spondylitis-functional-index" title="Learn more about Bath Ankylosing Spondylitis Functional Index from ScienceDirect's AI-generated Topic Pages">Bath Ankylosing Spondylitis Functional Index</a><span><span><span><span>; CRP, <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/c-reactive-protein" title="Learn more about C Reactive Protein from ScienceDirect's AI-generated Topic Pages">C-reactive protein</a>; </span><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/hla-b27" title="Learn more about HLA-B27 from ScienceDirect's AI-generated Topic Pages">HLA-B27</a>, </span><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/human-leukocyte-antigen" title="Learn more about Human Leukocyte Antigen from ScienceDirect's AI-generated Topic Pages">human leukocyte antigen</a><span> B27; NBP, nocturnal <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/backache" title="Learn more about Backache from ScienceDirect's AI-generated Topic Pages">back pain</a>; </span></span><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/nonsteroid-antiinflammatory-agent" title="Learn more about Nonsteroid Antiinflammatory Agent from ScienceDirect's AI-generated Topic Pages">NSAID</a><span>, <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/nonsteroid-antiinflammatory-agent" title="Learn more about Nonsteroid Antiinflammatory Agent from ScienceDirect's AI-generated Topic Pages">non-steroidal anti-inflammatory drug</a>; PtGA, patient global assessment; SD, standard deviation; TBP, total back pain; ULN, upper limit of normal.</span></span></span></p>
<p></p>
<dl class="footnotes">
<dt id="tb1fn1">⁎</dt>
<dd><p id="notep0003"><em>p</em> &lt; 0.05.</p></dd>
<dt id="tb1fn2">⁎⁎</dt>
<dd><p id="notep0004"><em>p</em> &lt; 0.01.</p></dd>
<dt id="tb1fn3">⁎⁎⁎</dt>
<dd><p id="notep0005"><em>p</em> &lt; 0.001.</p></dd>
<dt id="tb1fn4">a</dt>
<dd><p id="notep0006">Prior
 NSAID was defined as 28 days prior to screening for studies 311, 314, 
and 402 but was defined as 6 months prior to screening for study 
16.0037.</p></dd>
</dl>
</div>